Literature DB >> 25491223

Saudi Oncology Society clinical management guideline series. Anal canal cancer 2014.

Shouki N Bazarbashi1, Ali M Alzahrani, Mohammed M Rahal, Ahmed S Al-Shehri, Ali H Aljubran, Nasser A Alsanea, Omar A Al-Obeed, Magdy S Kandil, Jamal E Zekri, Ashwaq A Al Olayan, Abdullah A Alsharm, Khaled S Balaraj.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25491223      PMCID： PMC4362169     

Source DB:  PubMed          Journal:  Saudi Med J        ISSN： 0379-5284            Impact factor:   1.484


× No keyword cloud information.
  7 in total

1.  Combination of cisplatin plus fluoropyrimidine chemotherapy effective against liver metastases from carcinoma of the anal canal.

Authors:  J A Ajani; C H Carrasco; D E Jackson; S Wallace
Journal:  Am J Med       Date:  1989-08       Impact factor: 4.965

2.  Predictors and patterns of recurrence after definitive chemoradiation for anal cancer.

Authors:  Prajnan Das; Sumita Bhatia; Cathy Eng; Jaffer A Ajani; John M Skibber; Miguel A Rodriguez-Bigas; George J Chang; Priya Bhosale; Marc E Delclos; Sunil Krishnan; Nora A Janjan; Christopher H Crane
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-03-26       Impact factor: 7.038

3.  The lung cancer management guidelines 2012.

Authors:  Abdul Rahman Jazieh
Journal:  J Infect Public Health       Date:  2012-11-06       Impact factor: 3.718

4.  Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups.

Authors:  H Bartelink; F Roelofsen; F Eschwege; P Rougier; J F Bosset; D G Gonzalez; D Peiffert; M van Glabbeke; M Pierart
Journal:  J Clin Oncol       Date:  1997-05       Impact factor: 44.544

5.  Outcomes of salvage surgery for epidermoid carcinoma of the anus following failed combined modality treatment.

Authors:  Gareth Eeson; Marcus Foo; Stephen Harrow; Gregor McGregor; John Hay
Journal:  Am J Surg       Date:  2011-05       Impact factor: 2.565

6.  Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin.

Authors:  Leonard L Gunderson; Kathryn A Winter; Jaffer A Ajani; John E Pedersen; Jennifer Moughan; Al B Benson; Charles R Thomas; Robert J Mayer; Michael G Haddock; Tyvin A Rich; Christopher G Willett
Journal:  J Clin Oncol       Date:  2012-11-13       Impact factor: 44.544

7.  Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study.

Authors:  M Flam; M John; T F Pajak; N Petrelli; R Myerson; S Doggett; J Quivey; M Rotman; H Kerman; L Coia; K Murray
Journal:  J Clin Oncol       Date:  1996-09       Impact factor: 44.544
  7 in total
  1 in total

Review 1.  Squamous cell anal cancer: Management and therapeutic options.

Authors:  Beatrice Pessia; Lucia Romano; Antonio Giuliani; Gianni Lazzarin; Francesco Carlei; Mario Schietroma
Journal:  Ann Med Surg (Lond)       Date:  2020-05-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.